Insomnie
Natural health product licensed in Canada
- Other names
- Code Rouge Insomnie, Real Relief Insomnia
- Licence holder
- Homeocan Inc.
- NPN or DIN-HM
- 80033774
- Status
- Active licence
- Licence date
- 18 July 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Homéopathique
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Lactose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 12 years | 2 Comprimé | 1 day |
Uses authorised in Canada
Médicament homéopathique pour aider à soulager les symptômes associés à l'insomnie.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ne pas utiliser si le sceau de sécurité est brisé. Ne pas administrer aux enfants de moins de 12 ans. Garder hors de la portée des enfants. Les femmes enceintes ou qui allaitent doivent consulter un praticien de la santé de prendre ce produit. Consulter un praticien de la santé si les symptômes persistent ou s'aggravent après 7 jours.
Source
Official Health Canada record, licence 80033774
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.